IL37 and idiopathic pulmonary fibrosis: IL-37-transgenic (-tg) mice were protected against a number of animal model diseases, including colitis, acute myocardial infarction, idiopathic pulmonary fibrosis (IPF), obesity-induced inflammation, allergic airway inflammation, and surgical operation-induced spinal cord injury, among others [5,6,7,8].